Research Resources
Development of Novel Clinical and Translational Methodologies
The Development of Novel Clinical and Translational Methodologies (DNCTM) Core
proposes to reduce barriers to translational research by developing and supporting
programs that catalyze the transition of preclinical research into viable investigational products ready for human testing. To this end, the DNCTM will assemble a collaborative network of experts and external resources that collectively support and enable the implementation of effective preclinical programs. This collaborative environment will have two primary aims:
- to extend the ITHS collaboratory into the larger research community enabling greater bidirectional access to expertise and resources for drug and device development
- to create and support consulting programs that facilitate development and commercialization of translational research
Contact:
Kim Folger Bruce, Ph.D.
Director of Research Partnerships Institute of Translational Health Sciences
Children's Hospital and Regional Medical Center
Metropolitan Park West, Mailstop MPW 5-4 1100
Olive Way, Suite 500 Seattle, WA 98101
Phone: 206-884-7533 FAX: 206-987-7505
Email: kim.bruce@seattlechildrens.org
Director:
Lynn M. Rose, PhD
Research Associate Professor, Pediatrics
Director, Clinical Operations, Cystic Fibrosis TDN Coordinating Center
Box 359300, MPW 5-4
Phone: 206 884-7540
FAX: 206 987-7505
lynn.rose@seattlechildrens.org